Top

Appili Therapeutics Inc.

TSXV Exchange | Jul 14, 2020, 11:20 AM EDT | Real-time price

APLI $ 1.05 RT
CHANGE
-0.01 (-0.9434%)
VOLUME
38,300
Day Low: 1.03
Day High: 1.07
Detailed Quote
Open: 1.07
High: 1.07
Beta: N/A
Shares Out.: 52,516,212
Total Shares (All Classes)2: 61,604,011
Prev. Close: 1.06
Low: 1.03
VWAP: 1.0525
Escrow Shares: 9,087,799
Market Cap (All Classes)2*: 64,684,212
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 61,604,011
EPS: -0.16
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 7.50
Market Cap1: 64,684,212
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir. More

News Headlines for Appili Therapeutics Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links

Note: as part of an update to TMX Money, this link will be removed on June 30, 2020. Users wishing to access InfoTSXV can continue to do so directly

News Headlines for Appili Therapeutics Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.